Survival analysis revealed that BC patients with higher YBX1 expression had lower overall survival (OS) and recurrence-free survival (RFS), suggesting an important role for YBX1 in BC (Supplementary Fig. S6A–D). Here, YBX1 is linked to breast cancer.